Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Embryonal precursors of Wilms tumor.

Coorens THH, Treger TD, Al-Saadi R, Moore L, Tran MGB, Mitchell TJ, Tugnait S, Thevanesan C, Young MD, Oliver TRW, Oostveen M, Collord G, Tarpey PS, Cagan A, Hooks Y, Brougham M, Reynolds BC, Barone G, Anderson J, Jorgensen M, Burke GAA, Visser J, Nicholson JC, Smeulders N, Mushtaq I, Stewart GD, Campbell PJ, Wedge DC, Martincorena I, Rampling D, Hook L, Warren AY, Coleman N, Chowdhury T, Sebire N, Drost J, Saeb-Parsy K, Stratton MR, Straathof K, Pritchard-Jones K, Behjati S.

Science. 2019 Dec 6;366(6470):1247-1251. doi: 10.1126/science.aax1323.

2.

Somatic mutations and clonal dynamics in healthy and cirrhotic human liver.

Brunner SF, Roberts ND, Wylie LA, Moore L, Aitken SJ, Davies SE, Sanders MA, Ellis P, Alder C, Hooks Y, Abascal F, Stratton MR, Martincorena I, Hoare M, Campbell PJ.

Nature. 2019 Oct;574(7779):538-542. doi: 10.1038/s41586-019-1670-9. Epub 2019 Oct 23.

PMID:
31645727
3.

Corrigendum to "Disruption of the potassium channel regulatory subunit KCNE2 causes iron-deficient anemia" [Experimental Hematology, Vol. 42, Issue 12, p1053-1058.e1].

Salsbury G, Cambridge EL, McIntyre Z, Arends MJ, Karp NA, Isherwood C, Shannon C, Hooks Y; Sanger Mouse Genetics Project, Ramirez-Solis R, Adams DJ, White JK, Speak AO.

Exp Hematol. 2015 May;43(5):424. doi: 10.1016/j.exphem.2015.03.002. Epub 2015 Apr 1. No abstract available.

4.

Disruption of the potassium channel regulatory subunit KCNE2 causes iron-deficient anemia.

Salsbury G, Cambridge EL, McIntyre Z, Arends MJ, Karp NA, Isherwood C, Shannon C, Hooks Y; Sanger Mouse Genetics Project, Ramirez-Solis R, Adams DJ, White JK, Speak AO.

Exp Hematol. 2014 Dec;42(12):1053-8.e1. doi: 10.1016/j.exphem.2014.07.269. Epub 2014 Aug 12. Erratum in: Exp Hematol. 2015 May;43(5):424. Exp Hematol. 2015 May;43(5):424.

5.

Histopathology reveals correlative and unique phenotypes in a high-throughput mouse phenotyping screen.

Adissu HA, Estabel J, Sunter D, Tuck E, Hooks Y, Carragher DM, Clarke K, Karp NA; Sanger Mouse Genetics Project, Newbigging S, Jones N, Morikawa L, White JK, McKerlie C.

Dis Model Mech. 2014 May;7(5):515-24. doi: 10.1242/dmm.015263. Epub 2014 Mar 20.

6.

Application of phage display to high throughput antibody generation and characterization.

Schofield DJ, Pope AR, Clementel V, Buckell J, Chapple SDj, Clarke KF, Conquer JS, Crofts AM, Crowther SR, Dyson MR, Flack G, Griffin GJ, Hooks Y, Howat WJ, Kolb-Kokocinski A, Kunze S, Martin CD, Maslen GL, Mitchell JN, O'Sullivan M, Perera RL, Roake W, Shadbolt SP, Vincent KJ, Warford A, Wilson WE, Xie J, Young JL, McCafferty J.

Genome Biol. 2007;8(11):R254.

7.

A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation.

Cranston A, Carniti C, Martin S, Mondellini P, Hooks Y, Leyland J, Hodgson S, Clarke S, Pierotti M, Ponder BA, Bongarzone I.

Mol Endocrinol. 2006 Jul;20(7):1633-43. Epub 2006 Feb 9.

PMID:
16469774
8.

Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease.

Harrower TP, Tyers P, Hooks Y, Barker RA.

Exp Neurol. 2006 Jan;197(1):56-69. Epub 2005 Oct 24.

PMID:
16246328

Supplemental Content

Support Center